Example: Heart Attack

Search clinical trials for: Diazoxide

Total 29 results

NCT04086810

Not yet recruiting

An Open-Label Study of DCCR Tablet in Patients With PWS

Conditions: Prader-Willi Syndrome
NCT03714373

Active, not recruiting

Open-Label Extension Study of Diazoxide Choline in Patients With Prader-Willi Syndrome

Conditions: Prader-Willi Syndrome
NCT03685773

Suspended

The Role of Hepatic Denervation in the Dysregulation of Glucose Metabolism in Liver Transplant Recipients

Conditions: Diabetes Mellitus, Type 2; Glucose, High Blood; Glucose Metabolism Disorders
NCT03608163

Suspended

Novel Approach for the Prevention of Hypoglycemia Associated Autonomic Failure (HAAF)

Conditions: Diabetes Mellitus, Type 1; Hypoglycemia; Hypoglycemia Unawareness
NCT03566511

Suspended

Use of Functional MRI to Assess Functional Hypothalamic Activation in Response to Diazoxide

Conditions: Diabetes Mellitus, Type 2; Glucose, High Blood; Glucose Metabolism Disorders (Including Diabetes Mellitus)
NCT03540758

Suspended

Regulation of Endogenous Glucose Production by Central KATP Channels

Conditions: Type 2 Diabetes Mellitus; Glucose Metabolism Disorders; Glucose, High Blood
NCT03440814

Completed

A Study of Diazoxide Choline in Patients With Prader-Willi Syndrome

Conditions: Prader-Willi Syndrome
NCT02893618

Unknown status

A 5 Treatment Period Pharmacokinetic Study Evaluating Dose Proportionality and Food Effects of Diazoxide Choline Controlled-Release Tablet (DCCR)

Conditions: Prader-Willi Syndrome
NCT02779257

Withdrawn

Pasireotide Treatment for Neuroendocrine Tumor

Conditions: Gastro-enteropancreatic Neuroendocrine Tumor
NCT02049385

Terminated

Does Enhanced Glutamate Transporter Function Produce Antidepressant Effects in People With Major Depression?

Conditions: Depression
NCT02034071

Completed

Clinical Study of Diazoxide Choline Controlled-Release Tablet (DCCR) in Patients With Prader-Willi Syndrome

Conditions: Prader-Willi Syndrome
NCT01488136

Completed

Use of Diazoxide in Acute Hypoglycaemia

Conditions: Type 1 Diabetes
NCT01211847

Completed

Efficacy Study of Diazoxide Choline to Treat Hypertriglyceridemia

Conditions: Hypertriglyceridemia; Dyslipidemia
NCT01211860

Completed

Pharmacokinetic Study of Diazoxide Choline in Hypertriglyeridemic Subjects

Conditions: Hypertriglyceridmia
NCT01028846

Active, not recruiting

Central Mechanisms That Regulate Glucose Metabolism in Humans

Conditions: Type 2 Diabetes
NCT00994149

Unknown status

Diazoxide In the Management Of Hypoglycemic Neonates

Conditions: Infant, Newborn, Diseases; Pregnancy in Diabetics; Infant, Diabetic Mother; Hypoglycemia; Infant, Large for Gestational Age
NCT00989781

Completed

Mechanisms of Increased Androgen Production Among Women With Polycystic Ovary Syndrome

Conditions: Polycystic Ovary Syndrome
NCT00973271

Withdrawn

Diazoxide Choline Controlled-Release Tablet (DCCR) for Very High Triglycerides

Conditions: Hypertriglyceridemia
NCT00901823

Withdrawn

Open-Label, Single- and Multiple-Dose Pharmacokinetic Study of Diazoxide Choline

Conditions: Hypertriglyceridemia
NCT00892073

Completed

Hypothalamic Obesity Following Craniopharyngioma Surgery: A Pilot Trial of Combined Metformin and Diazoxide Therapy

Conditions: Hypothalamic Obesity
NCT00696475

Completed

Diazoxide Choline in Hypertriglyceridemia

Conditions: Hypertriglyceridemia
NCT00688857

Completed

Open-label Pharmacokinetic Study of Diazoxide Choline Coated vs. Uncoated Formulations

Conditions: Hypertriglyceridemia
NCT00683774

Completed

Insulin and Polycystic Ovary Syndrome

Conditions: PCOS
NCT00674440

Completed

Utility of [F-18] fluoroDOPA for Neonatal Hyperinsulinism

Conditions: Congenital Hyperinsulinism; Hyperinsulinism; Persistent Hyperinsulinemic Hypoglycemia of Infancy; CHI; PHHI
NCT00631033

Completed

DZX Mediated Insulin Suppression in Obese Men

Conditions: Obesity
NCT00306683

Completed

Effect of Diazoxide on the Obesity Secondary to Hypothalamic-pituitary Lesions

Conditions: Hypothalamic-pituitary Lesions; Craniopharyngiomas
NCT00184821

Completed

Ischemic Injury and Ischemic Preconditioning in Diabetes

Conditions: Diabetes Mellitus, Insulin-Dependent; Ischemia-Reperfusion Injury
NCT00151684

Completed

Diazoxide-Mediated Insulin Suppression in Hyperinsulinemic Obese Men

Conditions: Obesity; Hyperinsulinism
NCT00131755

Completed

Efficacy of Diazoxide in Type 1 Diabetes

Conditions: Diabetes Mellitus, Type 1